Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Boost rTMS for AVH - Therapeutic Response and Neurobiological Prediction Markers in Auditory Verbal Hallucinations

NCT03544333 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT03544333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03544333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Boost rTMS for AVH - Therapeutic Response and Neurobiological Prediction Markers in Auditory Verbal Hallucinations
Lead sponsor
Northwell Health
Phase
Not applicable
Overall status
Terminated
Start date
April 16, 2018
Completion date
January 22, 2019
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

auditory hallucination, schizophrenia